Exploring the Relationship Between Heart Rate Variability (HRV), Training Load, and Endurance Performance

NCT ID: NCT06964100

Last Updated: 2025-05-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-04-04

Study Completion Date

2025-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The ability of smart phones, aided by wearable devices (e.g. smart watches), to collect a variety of data, including physical activity, heart rate, and other exercise metrics, may provide a unique opportunity to understand real-world variability. The primary objective of this study is to test user engagement, app functionality, and feasibility of the newly developed Gatorade Sports Science Institute (GSSI) Labs App to conduct Real-World research studies. The secondary purpose of this study is to determine if Training Intensity (%Heart Rate maximum) in minutes during low heart rate variability (HRV) periods (below HRV baseline consecutive days) will have a negative relationship with post-study 5K (5 kilometer) running times as measured by their activity tracker, which could lead to personalized training recommendations using HRV. This study is conducted remotely, there are no in-person visits.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Heart rate variability (HRV) is an indirect biomarker of an individual's performance readiness and recovery. HRV is a ubiquitous biomarker measured by most consumer-grade wearable fitness trackers. However, there is little documented on the relationship between HRV, training load, and performance measures in the Real-World. Using activity trackers to monitor multiple physiological and subjective measures of health and wellness, subjects will perform self-administered 5 kilometer (5K) timed runs on Week 1, Week 4, and Week 8. Users will be instructed to run their 5K (3.1 miles) on the same outdoor course, indoor track, or treadmill to provide consistency in their performance assessments, with the understanding that there will be some limitations in creating a consistent performance assessment environment (i.e.; weather).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Rate Variability

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Actively participating in cardiovascular training (3-5 days/week).

Able to run a 5K (3.1 miles) distance at a self-selected location, three times over 8 weeks.

Age 18-65 years.

Subject is willing to refrain from vigorous exercise (light physical activity only) 24 hours prior to timed 5K assessment.

Subject is willing to avoid alcohol consumption 24 hours prior to 5K assessment.

Subject is willing to provide consent.

Subject is able to continuously wear their activity tracker, including during sleep, except when submerged underwater (i.e., swimming, bathing).

Subjects must have compatible wearable device (Android, Apple Health, Dexcom, Fitbit, Garmin, Health Connect, Oura, Polar, Whoop, and Withings).

Exclusion Criteria

Individual has a condition the Investigator believes would interfere with his ability to provide informed consent, comply with the project/study protocol, which might confound the interpretation of the project/study results or put the person at undue risk.

Those with a medical history that would interfere with the results of this study.

Those that have ≥1 risk factor for cardiovascular disease according to the American College of Sports Medicine.

Age: Men ≥ 45 yrs; Women ≥ 55 yrs.

Family History: Heart attack, "bypass surgery", or sudden death before the age of 55 yrs for father/brother, or before 65 yrs for mother/sister.

Cigarette Smoking: Current smoker, or have quit \< 6 months, or exposed to environmental smoke.

Sedentary lifestyle: Not participating in moderate (sweating) physical activity at least 3 days/week for 3-months.

Obesity: Body mass index ≥ 30 kg/m2 or waist girth 102 cm (40 inches) for men and 88 cm (35 inches) for women.

Hypertension: Systolic Blood Pressure ≥ 140 mmHg and/or Diastolic ≥90 mmHg, or taking medication.

Dyslipidemia: LDL ≥130 mg/dl, or HDL \< 40 mg/dl, or taking medication. Or triglycerides (TG) \> 200 \> mg/dl.

Pre-diabetes: Impaired fasting glucose (IFG) ≥ 100 mg/dl or oral glucose tolerance test (OGTT) ≥ 140 or ≤ 199 mg/dl confirmed by two different measurements.

Under the care of a physician.

Sleep disorders.

Using prescription medications that would impact sleep.

If female, you are not pregnant, planning to get pregnant or currently breast feeding.

Not able to wear activity tracker continuously.

Lack of proficiency in English.

Lack of proficiency or access to the internet and email address.

Participation in another clinical trial within the past 30 days.

Subject is employed by, or has a parent, guardian, or other immediate family member employed by a company that manufactures any products that compete with any Gatorade product. If subject is unsure if a company would be considered a competitor to Gatorade, they will be asked to please let the study investigator know the name of the other company and the nature of their relationship to that company before they sign the informed consent.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

PepsiCo Global R&D

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Corey Ungaro, do not contact to enroll, PhD

Role: PRINCIPAL_INVESTIGATOR

PepsiCo R&D Life Sciences, Sports Science

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Remote study, no physical site. Managed by Gatorade Sports Science Institute. Do not contact investigators to enroll. Recruitment is handled by an independent agency.

Chicago, Illinois, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Corey Ungaro, do not contact to enroll, PhD

Role: CONTACT

815-382-3213

Eric Freese, do not contact to enroll, PhD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Corey Ungaro, do not contact to participate, PhD

Role: primary

815-382-3213

Eric Freese, do not contact to participate, PhD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PEP-2502

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

HRV and Coaching Preparation Phase Study
NCT05150574 COMPLETED PHASE1
Hypoxia and Heart Rate Variability
NCT05606406 NOT_YET_RECRUITING NA